Showing 1 - 8 results of 8 for search 'Thomas, X', query time: 0.87s
Refine Results
-
1
Fighting Power: Interpretive Issues. The 1st Provisional Marine Brigade, 1950 by Hammes, T, Thomas X. Hammes
Published 2008Thesis -
2
-
3
Molecular dissection and testing of PRSS37 function through LC–MS/MS and the generation of a PRSS37 humanized mouse model by Courtney Sutton, Kaori Nozawa, Katarzyna Kent, Alexander Saltzman, Mei Leng, Sureshbabu Nagarajan, Anna Malovannaya, Masahito Ikawa, Thomas X. Garcia, Martin M. Matzuk
Published 2023-07-01
Article -
4
Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b by Raghwani, J, Thomas, X, Koekkoek, S, Schinkel, J, Molenkamp, R, van de Laar, T, Takebe, Y, Tanaka, Y, Mizokami, M, Rambaut, A, Pybus, O
Published 2012Journal article -
5
Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b. by Raghwani, J, Thomas, X, Koekkoek, S, Schinkel, J, Molenkamp, R, van de Laar, T, Takebe, Y, Tanaka, Y, Mizokami, M, Rambaut, A, Pybus, O
Published 2012Journal article -
6
A phase 3 study of Enasidenib (ENA) versus conventional care regimens (CCR) in older patients with late-stage mutant-IDH2 (MIDH2) relapsed/refractory acute myeloid leukemia (R/R AM... by Papayannidis, C, DiNardo, C, Montesinos, P, Schuh, A, Vyas, P, Wei, A, Ommen, H, Semochkin, S, Kim, H, Larson, R, Koprivnikar, J, Frankfurt, O, Thol, F, Chromik, J, Byrne, J, Pigneux, A, Thomas, X, Salamero, O, Vidriales, M, Doronin, V, Dohner, H, Fathi, A, Laille, E, Yu, X, Hasan, M, Martin-Regueira, P, de Botton, S
Published 2021Conference item -
7
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial by de Botton, S, Montesinos, P, Schuh, AC, Papayannidis, C, Vyas, P, Wei, AH, Ommen, H, Semochkin, S, Kim, H-J, Larson, RA, Koprivnikar, J, Frankfurt, O, Thol, F, Chromik, J, Byrne, J, Pigneux, A, Thomas, X, Salamero, O, Vidriales, MB, Doronin, V, Döhner, H, Fathi, AT, Laille, E, Yu, X, Hasan, M, Martin-Regueira, P, DiNardo, CD
Published 2022Journal article -
8
AML-262 Pivekimab Sunirine (PVEK, IMGN632) triplet with azacitidine and venetoclax shows broad activity in adverse genetic subsets of relapsed/refractory acute myeloid leukemia and... by Daver, N, Montesinos, P, Aribi, A, Martinelli, G, Altman, JK, Wang, ES, Roboz, GJ, Burke, PW, Gaidano, G, Walter, RB, Thomas, X, Jeyakumar, D, DeAngelo, DJ, Erba, HP, Todisco, E, Begna, K, Advani, A, Gastaud, L, de la Fuente, A, Curti, A, Mendez, LM, Vyas, P, Boissel, N, Vey, N, Recher, C, Longval, T, Platzbecker, U, Kapp-Schwörer, S, Schliemann, C, Konopleva, M, Torres, L, Sallman, DA, Marcucci, G, Marconi, G, Kantarjian, H, Sloss, CM, Malcolm, KE, Zweidler-McKay, PA, Sweet, K
Published 2022Journal article